Nanxin Pharmaceutical: Stock to be subject to other risk warnings, trading suspended for one day starting tomorrow
Nanxin Pharmaceutical has received an administrative penalty from the Hunan Securities Regulatory Bureau for alleged information disclosure violations. The company and its personnel face a total fine of 11.5 million yuan, and its stock will be suspended for one day before being subject to risk warnings. Separately, U.S. Steel announced plans to invest up to $2.5 billion in a new hot-rolled coil plant in Pennsylvania. AI